Accelerate Diagnostics (NASDAQ:AXDX) expects 2020 revenues of $16 – 18M, up 72 – 94% from 2019 but well below consensus of ~$28M.
CEO Jack Phillips will be presenting this forecast and a business overview at JPM20 today.
Shares down 27% premarket on light volume.
Source: Press Release
#JPM20
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.